Filters

BAIAP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

BAIAP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetBAIAP2 Lentiviral Vector (EF1a) (pLenti-GIII-EF1a)
Short nameBAIAP2 Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (EF1a) (pLenti-GIII-EF1a), BAIAP2 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 947
Gene BAIAP2
Long gene name BAI1 associated protein 2
Synonyms gene name BAI1-associated protein 2
Synonyms BAP2 IRSp53
Synonyms name insulin receptor substrate of 53 kDa
Locus 17q25, 3
Discovery year 1999-02-26
GenBank acession AB015019
Entrez gene record 10458
Pubmed identfication 10343108
Classification I-BAR domain containing
Havana BLAST/BLAT OTTHUMG00000177698

Similar products

Subscribe to our Newsletter